{"schema_version":"secwatch.filing_event.v1","accession":"0001816590-25-000094","form_type":"8-K","ticker":"CMPS","cik":"0001816590","company_name":"COMPASS Pathways plc","filed_at":"2025-07-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:45.095648+00:00","generated_at":"2026-05-17T23:46:53.772130+00:00","sec_items":["5.02","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Compass Pathways appoints Justin Gover to board; Dr. Linda McGoldrick to retire Oct 31","bullets":["Justin Gover appointed as Class III director effective July 29, 2025; joins audit/risk and scientific committees.","Gover receives initial option for 52,000 ordinary shares vesting over 3 years; annual retainer of $40,000 plus committee fees.","Linda McGoldrick to retire from board effective October 31, 2025; no disagreement with company.","Gover was founding CEO of GW Pharmaceuticals (sold to Jazz for $7B) and led Epidiolex development/commercialization.","Currently also serves on Xenon Pharmaceuticals (XENE) board; brings 25+ years biopharma experience."],"urls":{"canonical":"https://secwatch.observer/filing/0001816590-25-000094","json":"https://secwatch.observer/filing/0001816590-25-000094.json","markdown":"https://secwatch.observer/filing/0001816590-25-000094.md","text":"https://secwatch.observer/filing/0001816590-25-000094.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1816590/000181659025000094/0001816590-25-000094-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1816590/000181659025000094/cmps-20250728.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T23:46:53.772130+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}